Publication:
Follow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone

Simple item page
dc.contributor.buuauthorNak, Deniz
dc.contributor.buuauthorNak, Yavuz
dc.contributor.buuauthorTuna, Bilginer
dc.contributor.departmentVeterinerlik Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentKadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.contributor.researcheridAAH-5494-2021
dc.contributor.scopusid9280090000
dc.contributor.scopusid8615464000
dc.contributor.scopusid9280090300
dc.date.accessioned2021-12-13T07:19:03Z
dc.date.available2021-12-13T07:19:03Z
dc.date.issued2009-06
dc.description.abstractThe aim of this study was to determine the therapeutic Success Of the medical treatment of pyometra with the antigestagen aglepristone and to document the recurrence rate in relation to the time interval after treatment with antigestagens in cats. Ten cats, 2-13 years of age and nulliparous were used in the Study. The cats were treated with aglepristone at a dose of 10 mg/kg body weight subcutaneously on days 1, 2, 7 and 14 (if not cured). In addition, trimethoprim/sulphadoxine was also administered at a dose of 15 mg/kg body weight subcutaneously once a day for 7 days. Nine out of the 10 cats responded well to treatment. No recurrence was observed in a follow-up period of 2 years. No side effects were observed. The data suggest that aglepristone treatment is a promising approach for the medical treatment of pyometra in cats.
dc.identifier.citationNak, D. vd. (2009). "Follow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone". Journal of Feline Medicine and Surgery, 11(6), 499-502.
dc.identifier.endpage502
dc.identifier.issn1098-612X
dc.identifier.issue6
dc.identifier.pubmed19097817
dc.identifier.scopus2-s2.0-67349148579
dc.identifier.startpage499
dc.identifier.urihttps://doi.org/10.1016/j.jfms.2008.09.006
dc.identifier.urihttps://journals.sagepub.com/doi/10.1016/j.jfms.2008.09.006
dc.identifier.urihttp://hdl.handle.net/11452/23190
dc.identifier.volume11
dc.identifier.wos000267109400014
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSage Publications
dc.relation.journalJournal of Feline Medicine and Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectReproduction
dc.subjectHyperplasia
dc.subjectVeterinary sciences
dc.subject.emtreeAglepristone
dc.subject.emtreeAntiinfective agent
dc.subject.emtreeEstrane derivative
dc.subject.emtreeGestagen
dc.subject.emtreeSulfadoxine
dc.subject.emtreeTrimethoprim
dc.subject.emtreeAnimal
dc.subject.emtreeAnimal disease
dc.subject.emtreeArticle
dc.subject.emtreeCat
dc.subject.emtreeCat disease
dc.subject.emtreeDrug antagonism
dc.subject.emtreeDrug combination
dc.subject.emtreeFemale
dc.subject.emtreeMale
dc.subject.emtreePyometra
dc.subject.emtreeSubcutaneous drug administration
dc.subject.emtreeTreatment outcome
dc.subject.meshAnimals
dc.subject.meshAnti-bacterial agents
dc.subject.meshCat diseases
dc.subject.meshCats
dc.subject.meshDrug therapy, combination
dc.subject.meshEstrenes
dc.subject.meshFemale
dc.subject.meshInjections, subcutaneous
dc.subject.meshMale
dc.subject.meshProgestins
dc.subject.meshPyometra
dc.subject.meshSulfadoxine
dc.subject.meshTreatment outcome
dc.subject.meshTrimethoprim
dc.subject.scopusPyometra; Bitches; Deslorelin
dc.subject.wosVeterinary sciences
dc.titleFollow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone
dc.typeArticle
dc.wos.quartileQ2
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Kadın Hastalıkları ve Doğum Ana Bilim Dalı
local.contributor.departmentVeterinerlik Fakültesi
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications